Browse RMM Directory A-Z

${pdf_link}$

FABHALTA - Vaccination Confirmation Form

Part of the Controlled Access, this Vaccination Confirmation Form verifies that iptacopan can only be dispensed once Novartis receives written confirmation that each patient has received vaccination against N. meningitidis and S. pneumoniae infections and/or receipt of prophylactic antibiotic treatment (in accordance with national guidelines).

${pdf_link}$

FABHALTA Patient safety card

This material has been developed and funded by Novartis Pharmaceuticals UK Ltd and is intended only for UK patients with paroxysmal nocturnal haemoglobinuria (PNH) who have been prescribed iptacopan.

${pdf_link}$

Healthcare Professional’s Guide to FABHALTA

This brochure aims to provide guidance and mitigate possible risk of infections during iptacopan treatment, and haemolysis after discontinuation.

${pdf_link}$

Patient and caregiver guide to treatment with FABHALTA

This material has been developed and funded by Novartis Pharmaceuticals UK Ltd and is intended only for UK patients with paroxysmal nocturnal haemoglobinuria (PNH) who have been prescribed iptacopan and their caregivers. This guide aims to provide you with important safety information for iptacopan.

${pdf_link}$

Fabrazyme (agalsidase beta) - Home Infusion HCP Manual - Risk Minimisation Information for Healthcare Professionals

The objective of this document is to provide guidance to healthcare professionals for the management of patients receiving Fabrazyme (agalsidase beta) at home. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

${pdf_link}$

Fabrazyme (agalsidase beta) - Home Infusion Patient Manual - Risk Minimisation Information for Patients

The objective of this document is to provide patients with guidance on how to receive Fabrazyme (agalsidase beta) at home. It is the responsibility of the treating physician to supply this material to patients only if the treating physician decides that the patient is eligible for home infusion treatment. For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

${pdf_link}$

Fabrazyme (agalsidase beta)Home Infusion Patient Logbook- Risk Minimisation Information for Patients

For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected]

${pdf_link}$

Farydak patient card cycles 1-8

Compliance card to keep track of the Farydak regimen

${pdf_link}$

Farydak patient card cycles 9-16

Compliance card to keep track of Farydak regimen

${pdf_link}$

CHCs - Checklist for Prescribers

Combined Hormonal Contraceptives - checklist for prescribers

${pdf_link}$

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.

${pdf_link}$

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

${pdf_link}$

CHCs - Checklist for Prescribers

Combined Hormonal Contraceptives - checklist for prescribers

${pdf_link}$

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.

${pdf_link}$

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

${pdf_link}$

CHCs - Checklist for Prescribers

Combined Hormonal Contraceptives - checklist for prescribers

${pdf_link}$

CHCs - Q&A on Important Info for Women

Combined hormonal contraceptives: Q&As about the important information for women.

${pdf_link}$

CHCs - Risk of Blood Clots with CHCs

Important Information for women about risk of blood clots with combined hormonal contraceptives.

${pdf_link}$

Fenapin 20 mg/ml Solution for Infusion Card

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

${pdf_link}$

Important risk minimisation information for healthcare professionals about treatment on Fenhuma

The Fenhuma® Prescriber Guide is designed to support healthcare professionals

in the diagnosis of breakthrough pain (BTP) in patients suffering from cancer. It

provides guidance on the initiation, administration and titration of Fenhuma ® and

promotes engagement with patients and their carers. The booklet should be

used in conjunction with the Fenhuma ® Summary of Product Characteristics

(SPC).

${pdf_link}$

Important risk minimisation information for patients and their carers about treatment on Fenhuma

Booklet - Important risk minimisation information for patients and their carers

${pdf_link}$

Guide for healthcare professionals on the safe use of Fibrovein

Guide describes key safety concerns and how to avoid them

${pdf_link}$

Finasteride- Patient Alert Card for 1mg

${pdf_link}$

Finasteride- Patient Alert Card for 5 mg

Finasteride- Patient Alert Card for 5mg

${pdf_link}$

Patient Alert Card for Finasteride 1 mg film-coated tablets

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

${pdf_link}$

Patient Alert Card for Finasteride 5 mg film-coated tablets

Alert card containing important safety information to be given to patients for them to carry with them at all times and show to any healthcare professional involved in their care.

${pdf_link}$

Finasteride - Patient Alert Card

Patient Alert Card

${pdf_link}$

Finasteride-Patient Alert Card

${pdf_link}$

Finasteride - Patient alert card

Patient Alert Card for Finasteride 5mg Tablets

${pdf_link}$

Finasteride 1mg tablet

Patient Alert card for Finasteride 1mg Tablets

${pdf_link}$

Fingolimod patient guide

${pdf_link}$

Fingolimod patient information-Pregnancy-Specific Patient Reminder Card

${pdf_link}$

Fingolimod prescriber's checklist

${pdf_link}$

Fingolimod - Patients Information Booklet - for Patients

This patient booklet contains important things to remember about Fingolimod treatment for patients, parents and caregivers

${pdf_link}$

Fingolimod - Pregnancy-Specific Patient Reminder Card - for patients

This reminder card contains pregnancy-specific safety information about Fingolimod treatment

${pdf_link}$

Fingolimod - Prescribers checklist - for Healthcare Professionals

This checklist outlines important points to remember before, during and after treatment

${external_link}$

Fingolimod Patient Information Booklet

Important things to remember about Fingolimod treatment for patients, parents and caregivers

${external_link}$

Fingolimod Pregnancy-Specific Patient Reminder Card

Fingolimod Pregnancy-specific patient reminder card

${external_link}$

Fingolimod Prescribers Checklist

Fingolimod Prescriber’s Checklist – Important points to remember before, during and after treatment

${pdf_link}$

Fingolimod Pregnancy-Specific Patient Reminder Card

Fingolimod Pregnancy-Specific Patient Reminder Card Reminder card Pregnancy-Specific for patients that have been prescribed fingolimod. It contains information on before starting fingolimod treatment, while you are taking fingolimod and after stopping fingolimod treatment.

${pdf_link}$

Important things for Patients, Parents and Caregivers to remember about treatment on Fingolimod

Booklet for patients that have been prescribed fingolimod. It contains important information for patients, parents and caregivers including what is multiple sclerosis(MS), how does Fingolimod work, how to take fingolimod the right way and why monitoring your treatment is important.

${pdf_link}$

Risk Minimisation Materials

Fabhalta

Novartis Pharmaceuticals UK Ltd

Fabrazyme

SANOFI

Farydak

pharmaand GmbH

Femodene

Bayer plc

Femodene ED

Bayer plc

Femodette

Bayer plc

Fenapin

Galvany Pharma Ltd

Fenhuma

Glenmark Pharmaceuticals Europe Ltd

Fibrovein

STD Pharmaceutical Products Ltd

Finasteride

Amarox Limited

Aurobindo Pharma - Milpharm Ltd.

Cipla EU Ltd

Dr. Reddy's Laboratories (UK) Ltd

Strandhaven Limited t/a Somex Pharma

Fingolimod

Amarox Limited

Dr. Reddy's Laboratories (UK) Ltd

Flynn Pharma Ltd

Glenmark Pharmaceuticals Europe Ltd

MSN Laboratories Europe Ltd

Mylan

Ranbaxy (UK) Limited a Sun Pharmaceutical Company

Sandoz Limited

Teva UK Limited

Tillomed Laboratories Ltd

Zentiva

Fintepla

UCB Pharma Limited

Flixabi

Biogen Biosimilars

You are trying to reach document intended for healthcare professionals only.

You are trying to reach document intended for healthcare professionals only.